(SFQ) SAF Holland - Ratings and Ratios
Axles, Suspension, Fifth Wheels, Landing Gear, Coupling
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.86% |
| Yield on Cost 5y | 9.96% |
| Yield CAGR 5y | 55.84% |
| Payout Consistency | 50.3% |
| Payout Ratio | 46.7% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 30.5% |
| Value at Risk 5%th | 49.3% |
| Relative Tail Risk | -1.76% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.51 |
| Alpha | 4.42 |
| CAGR/Max DD | 0.71 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.472 |
| Beta | 0.340 |
| Beta Downside | 0.439 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.65% |
| Mean DD | 10.70% |
| Median DD | 10.16% |
Description: SFQ SAF Holland October 22, 2025
SAF-Holland SE (XETRA: SFQ) is a German-based supplier of chassis-related assemblies and components for commercial-vehicle OEMs, including axles, air-suspension, fifth-wheel couplings, kingpins, rims, landing-gears, braking (including EBS) and lighting systems. The product portfolio is sold under multiple brands such as SAF, Holland, Haldex and TrailerMaster, and the company serves markets across Europe, the Middle East, Africa, the Americas and Asia-Pacific.
Key quantitative touch-points (as of FY 2023) are an estimated €2.1 bn of revenue, an EBIT margin of roughly 6 % and a net-debt-to-EBITDA ratio of 1.8×, indicating moderate leverage. The business is sensitive to two sector drivers: (1) the cyclicality of commercial-vehicle production, which is currently being moderated by a gradual recovery in European truck sales after the 2022-23 slowdown; and (2) regulatory pressure on emissions and safety, prompting OEMs to adopt advanced air-suspension and electronic braking systems-areas where SAF-Holland holds a competitive product suite. A material risk is the exposure to supply-chain bottlenecks in steel and electronic components, which could compress margins if not managed.
For a deeper, data-rich assessment of SAF-Holland’s valuation and risk profile, you may find the analytics on ValueRay useful as a next step in your research.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (55.7m TTM) > 0 and > 6% of Revenue (6% = 104.0m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA -1.24pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 28.75% (prev 25.14%; Δ 3.61pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.09 (>3.0%) and CFO 166.6m > Net Income 55.7m (YES >=105%, WARN >=100%) |
| Net Debt (437.6m) to EBITDA (168.8m) ratio: 2.59 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.12 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (45.4m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 22.47% (prev 21.89%; Δ 0.58pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 100.5% (prev 117.3%; Δ -16.86pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.44 (EBITDA TTM 168.8m / Interest Expense TTM 69.1m) >= 6 (WARN >= 3) |
Altman Z'' 2.90
| (A) 0.28 = (Total Current Assets 942.2m - Total Current Liabilities 444.0m) / Total Assets 1.77b |
| (B) 0.14 = Retained Earnings (Balance) 250.3m / Total Assets 1.77b |
| (C) 0.06 = EBIT TTM 99.5m / Avg Total Assets 1.73b |
| (D) 0.19 = Book Value of Equity 250.3m / Total Liabilities 1.29b |
| Total Rating: 2.90 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 64.43
| 1. Piotroski 4.50pt |
| 2. FCF Yield 10.24% |
| 3. FCF Margin 6.22% |
| 4. Debt/Equity 1.62 |
| 5. Debt/Ebitda 2.59 |
| 6. ROIC - WACC (= 1.73)% |
| 7. RoE 11.14% |
| 8. Rev. Trend 40.16% |
| 9. EPS Trend 41.81% |
What is the price of SFQ shares?
Over the past week, the price has changed by +5.69%, over one month by -1.36%, over three months by -8.69% and over the past year by +14.41%.
Is SFQ a buy, sell or hold?
What are the forecasts/targets for the SFQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.4 | 40.7% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 17 | 17% |
SFQ Fundamental Data Overview November 23, 2025
Market Cap EUR = 622.8m (622.8m EUR * 1.0 EUR.EUR)
P/E Trailing = 11.1545
P/S = 0.3594
P/B = 1.2918
Beta = 1.651
Revenue TTM = 1.73b EUR
EBIT TTM = 99.5m EUR
EBITDA TTM = 168.8m EUR
Long Term Debt = 637.0m EUR (from longTermDebt, last quarter)
Short Term Debt = 144.3m EUR (from shortLongTermDebt, last quarter)
Debt = 774.2m EUR (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 437.6m EUR (from netDebt column, last quarter)
Enterprise Value = 1.05b EUR (622.8m + Debt 774.2m - CCE 343.6m)
Interest Coverage Ratio = 1.44 (Ebit TTM 99.5m / Interest Expense TTM 69.1m)
FCF Yield = 10.24% (FCF TTM 107.9m / Enterprise Value 1.05b)
FCF Margin = 6.22% (FCF TTM 107.9m / Revenue TTM 1.73b)
Net Margin = 3.22% (Net Income TTM 55.7m / Revenue TTM 1.73b)
Gross Margin = 22.47% ((Revenue TTM 1.73b - Cost of Revenue TTM 1.34b) / Revenue TTM)
Gross Margin QoQ = 21.63% (prev 22.45%)
Tobins Q-Ratio = 0.59 (Enterprise Value 1.05b / Total Assets 1.77b)
Interest Expense / Debt = 1.33% (Interest Expense 10.3m / Debt 774.2m)
Taxrate = 33.94% (7.15m / 21.1m)
NOPAT = 65.7m (EBIT 99.5m * (1 - 33.94%))
Current Ratio = 2.12 (Total Current Assets 942.2m / Total Current Liabilities 444.0m)
Debt / Equity = 1.62 (Debt 774.2m / totalStockholderEquity, last quarter 477.2m)
Debt / EBITDA = 2.59 (Net Debt 437.6m / EBITDA 168.8m)
Debt / FCF = 4.06 (Net Debt 437.6m / FCF TTM 107.9m)
Total Stockholder Equity = 500.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.15% (Net Income 55.7m / Total Assets 1.77b)
RoE = 11.14% (Net Income TTM 55.7m / Total Stockholder Equity 500.2m)
RoCE = 8.75% (EBIT 99.5m / Capital Employed (Equity 500.2m + L.T.Debt 637.0m))
RoIC = 5.46% (NOPAT 65.7m / Invested Capital 1.20b)
WACC = 3.73% (E(622.8m)/V(1.40b) * Re(7.27%) + D(774.2m)/V(1.40b) * Rd(1.33%) * (1-Tc(0.34)))
Discount Rate = 7.27% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 81.65 | Cagr: 0.14%
[DCF Debug] Terminal Value 80.03% ; FCFE base≈113.9m ; Y1≈129.4m ; Y5≈177.0m
Fair Price DCF = 67.48 (DCF Value 3.06b / Shares Outstanding 45.4m; 5y FCF grow 15.80% → 3.0% )
EPS Correlation: 41.81 | EPS CAGR: 98.12% | SUE: 1.68 | # QB: 1
Revenue Correlation: 40.16 | Revenue CAGR: 7.17% | SUE: -0.01 | # QB: 0